Ευρωπαϊκή Ένωση - Γαλλικά - EMA (European Medicines Agency)

eigerbio europe limited - lonafarnib - progeria; laminopathies - d'autres tractus digestif et le métabolisme des produits, - zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of hutchinson-gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous lmna mutation with progerin-like protein accumulation or a homozygous or compound heterozygous zmpste24 mutation.

Ελβετία - Γαλλικά - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - candesartanum cilexetilum - comprimés - candesartanum cilexetilum 4 mg, carmellosum calcicum, hydroxypropylcellulosum, lactosum monohydricum 93.4 mg, magnesii stearas, maydis amylum, macrogolum 8000, pro compresso. - hypertension artérielle essentielle et l'insuffisance cardiaque - synthetika

Ελβετία - Γαλλικά - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - candesartanum cilexetilum - comprimés - candesartanum cilexetilum 8 mg, carmellosum calcicum, hydroxypropylcellulosum, lactosum monohydricum 89.4 mg, magnesii stearas, maydis amylum, macrogolum 8000, e 172 (rubrum), pro compresso. - hypertension artérielle essentielle et l'insuffisance cardiaque - synthetika

Ελβετία - Γαλλικά - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - candesartanum cilexetilum - comprimés - candesartanum cilexetilum 16 mg, carmellosum calcicum, hydroxypropylcellulosum, lactosum monohydricum 81.4 mg, magnesii stearas, maydis amylum, macrogolum 8000, e 172 (rubrum), pro compresso. - hypertension artérielle essentielle et l'insuffisance cardiaque - synthetika

Ελβετία - Γαλλικά - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - candesartanum cilexetilum - comprimés - candesartanum cilexetilum 32 mg, hydroxypropylcellulosum, macrogolum 8000, e 172 (rubrum), lactosum monohydricum 162.8 mg, maydis amylum, carmellosum calcicum, magnesii stearas, pro compresso. - hypertension artérielle essentielle et l'insuffisance cardiaque - synthetika

Ελβετία - Γαλλικά - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - candesartanum cilexetilum, hydrochlorothiazidum - comprimés - candesartanum cilexetilum 8 mg, hydrochlorothiazidum 12.5 mg, carmellosum calcicum, hydroxypropylcellulosum, lactosum monohydricum 77 mg, magnesii stearas, maydis amylum, macrogolum 8000, pro compresso. - essentielle hypertonie - synthetika

Ελβετία - Γαλλικά - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - candesartanum cilexetilum, hydrochlorothiazidum - comprimés - candesartanum cilexetilum 16 mg, hydrochlorothiazidum 12.5 mg, carmellosum calcicum, hydroxypropylcellulosum, lactosum monohydricum 68 mg, magnesii stearas, maydis amylum, macrogolum 8000, e 172 (flavum), e 172 (rubrum), pro compresso. - essentielle hypertonie - synthetika

Ελβετία - Γαλλικά - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - candesartanum cilexetilum, hydrochlorothiazidum - comprimés - candesartanum cilexetilum 32 mg, hydrochlorothiazidum 12.5 mg, carmellosum calcicum, hydroxypropylcellulosum, lactosum monohydricum 148.5 mg, magnesii stearas, maydis amylum, macrogolum, e 172 (flavum), pro compresso. - essentielle hypertonie - synthetika

Ελβετία - Γαλλικά - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - candesartanum cilexetilum, hydrochlorothiazidum - comprimés - candesartanum cilexetilum 32 mg, hydrochlorothiazidum 25 mg, carmellosum calcicum, hydroxypropylcellulosum, lactosum monohydricum 136 mg, magnesii stearas, maydis amylum, macrogolum, e 172 (flavum), e 172 (rubrum), pro compresso. - essentielle hypertonie - synthetika